Boxmeer, Netherlands
Merck Animal Health broke ground in July of 2011 on an $18 million vaccine manufacturing expansion in Boxmeer in the Netherlands. The cGMP project will double available tissue culture space and will support accelerated production of veterinary vaccines. Completion is expected by early 2013.
